The costimulation-regulated duration of PKB activation controls T cell longevity

被引:167
作者
Song, JX
Salek-Ardakani, S
Rogers, PR
Cheng, M
Van Parijs, L
Croft, M [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA
[2] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
关键词
D O I
10.1038/ni1030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A brief antigenic stimulus can promote T cell proliferation, but the duration and nature of intracellular signals required for survival are unclear. Here we show that in the absence of OX40 costimulation, antigen-activated CD4(+) cells are short-lived because the activity of protein kinase B (PKB; also known as Akt) is not maintained over time. Activated T cells that express a dominant-negative variant of PKB also undergo apoptosis, reproducing the OX40-deficient phenotype. In contrast, an active form of PKB prevents downregulation of antiapoptotic proteins in OX40-deficient T cells, rescues antigen-induced cell survival in vivo, and controls inflammation in recall responses. Thus, sustained and periodic PKB signaling has an integral role in regulating T cell longevity.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 49 条
  • [31] Two-photon imaging of lymphocyte motility and antigen response in intact lymph node
    Miller, MJ
    Wei, SH
    Parker, I
    Cahalan, MD
    [J]. SCIENCE, 2002, 296 (5574) : 1869 - 1873
  • [32] Ohshima Y, 1997, J IMMUNOL, V159, P3838
  • [33] Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
    Pap, M
    Cooper, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) : 19929 - 19932
  • [34] Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B
    Parry, RV
    Reif, K
    Smith, G
    Sansom, DM
    Hemmings, BA
    Ward, SG
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (10) : 2495 - 2501
  • [35] Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation
    Parsons, MJ
    Jones, RG
    Tsao, MS
    Odermatt, B
    Ohashi, PS
    Woodgett, JR
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (01) : 42 - 48
  • [36] Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology
    Plas, DR
    Talapatra, S
    Edinger, AL
    Rathmell, JC
    Thompson, CB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) : 12041 - 12048
  • [37] Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
    Pugazhenthi, S
    Nesterova, A
    Sable, C
    Heidenreich, KA
    Boxer, LM
    Heasley, LE
    Reusch, JEB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) : 10761 - 10766
  • [38] Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma
    Rathmell, JC
    Elstrom, RL
    Cinalli, RM
    Thompson, CB
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (08) : 2223 - 2232
  • [39] OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells
    Rogers, PR
    Song, JX
    Gramaglia, I
    Killeen, N
    Croft, M
    [J]. IMMUNITY, 2001, 15 (03) : 445 - 455
  • [40] OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation
    Salek-Ardakani, S
    Song, JX
    Halteman, BS
    Jember, AGH
    Akiba, H
    Yagita, H
    Croft, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) : 315 - 324